You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

CLINICAL TRIALS PROFILE FOR ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03499704 ↗ A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by Alogliptin and Metformin Therapy Recruiting Celltrion Pharm, Inc. Phase 4 2020-02-11 The purpose of this study is to assess the pioglitazone plus alogliptin plus metformin is non-inferior to dapagliflozin plus alogliptin plus metformin on glycosylated haemoglobin (HbA1c) change from baseline at Week 52.
NCT03499704 ↗ A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by Alogliptin and Metformin Therapy Recruiting Takeda Phase 4 2020-02-11 The purpose of this study is to assess the pioglitazone plus alogliptin plus metformin is non-inferior to dapagliflozin plus alogliptin plus metformin on glycosylated haemoglobin (HbA1c) change from baseline at Week 52.
NCT04470310 ↗ Glimepiride, Alogliptin and Alogliptin+Pioglitazone Combination Active, not recruiting Seoul National University Hospital Phase 4 2015-12-31 - This trial is a three-armed, open label, random assignment trial. - The research subjects are patients who are first starting their treatment or patients who have failed with the metformin treatment and are changing their medication. They will be assigned to one of the following treatment groups: the glimepiride monotherapy treatment group, the alogliptin monotherapy treatment group, and the alogliptin - pioglitazone combination therapy treatment group - This trial is a prospective trial which will conduct surveys 6 times over the course of the 6 months in which each treatment group is administered drugs (Week -2, Baseline, Week 4, Week 12, Week 24, follow-up safety survey). - This trial is a multicenter clinical trial which will be conducted at more than 5 general hospital medical institutions in the vicinity of the capital.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE

Condition Name

Condition Name for ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE
Intervention Trials
Diabetes Mellitus, Type 2 1
Type 2 Diabetes Mellitus 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE
Intervention Trials
Diabetes Mellitus, Type 2 2
Diabetes Mellitus 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE

Trials by Country

Trials by Country for ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE
Location Trials
Korea, Republic of 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE

Clinical Trial Phase

Clinical Trial Phase for ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE
Clinical Trial Phase Trials
Phase 4 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE
Clinical Trial Phase Trials
Active, not recruiting 1
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE

Sponsor Name

Sponsor Name for ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE
Sponsor Trials
Celltrion Pharm, Inc. 1
Takeda 1
Seoul National University Hospital 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE
Sponsor Trials
Industry 2
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.